In this study, we mutated autophosphorylation sites in Rad53 based on their conservation with previously identified autophosphorylation sites in the mammalian Rad53 ortholog, Chk2. As with wild-type Rad53, the autophosphorylation mutant, rad53-TA, undergoes Mec1/Tel1-dependent interactions with Rad9 and Dun1 in response to genotoxic stress. Whereas rad53-TA in vitro kinase activity is severely impaired, the rad53-TA strains are not completely deficient for cell-cycle checkpoint functions, indicating that the mutant kinase retains a basal level of function. We describe a genetic interaction among Rad53, Dun1, and the 14-3-3 proteins Bmh1 and Bmh2 and present evidence that 14-3-3 proteins directly facilitate Rad53 function in vivo. The data presented account for the previously observed checkpoint defects associated with 14-3-3 mutants in Saccharomyces pombe and Saccharomyces cerevisiae. The 14-3-3 functional interaction appears to modulate Rad53 activity, reminiscent of 14-3-3's effect on human Raf1 kinase and distinct from the indirect mode of regulation by 14-3-3 observed for Chk1 or Cdc25.
D
NA damage and DNA replication checkpoints are highly conserved cellular surveillance systems to maintain genome integrity in the face of various genotoxic stresses (reviewed in refs. 1 and 2). The checkpoints are activated via signal transduction networks that are schematically comparable to other cellular signal transduction pathways (e.g., MAP kinase pathways). Once damage is detected, PIKKs (PI3-kinase like kinases Mec1 and Tel1 in Saccharomyces cerevisiae and ATM and ATR in mammals) are responsible for the initial transduction of the DNA damage signal.
PIKK-dependent phosphorylation of downstream targets facilitates a series of physical interactions that involve the phosphopeptide-binding domains, FHA (forkhead-associated) and BRCT (Brca1 C terminus), found in the numerous DNA damage-response proteins (3, 4) . Foremost among such targets are mediator proteins such as Rad9 and Mrc1 as well as effector kinases such as Rad53, which require PIKK phosphorylation for subsequent activation of the DNA damage-response pathway (5-7). Upon DNA damage or DNA replication stress, Rad53 and its orthologs in Saccharomyces pombe (Cds1) and mammals (Chk2) are phosphorylated by PIKKs and then subsequently undergo autophosphorylation to become fully active (5, (8) (9) (10) (11) (12) (13) .
Autophoshorylation of Rad53 depends on FHA-dependent interaction with its mediator proteins Rad9 and Mrc1, which is potentiated by PIKK-phosphorylation (12) (13) (14) (15) . Evidence suggests that the Chk2 and Cds1 FHA domains also mediate self-oligomerization in the course of autophosphorylation (11, 13, 16, 17) . Finally, the Rad53 substrate Dun1 also has a FHA domain that engages Rad53 through PIKK-dependent phosphorylation sites (18, 19) . The formation of these PIKKdependent protein complexes appears to be the juncture at which the DNA damage or replication stress signal is amplified.
The activation-loop autophosphorylation sites in Chk2, T383/ T387, are conserved in yeast orthologues Rad53 and Cds1 (11, 13) [see supporting information (SI) Fig. 7 ], and Rad53 T354 has been confirmed as a bona fide autophosphorylation sites by mass spectrometric analysis (12) . We hypothesized that rad53 autophosphorylation site mutants would retain PIKK phosphorylation-dependent basal activity but would be impaired in signal amplification. The rad53 mutant proteins would thus have a higher level of activity than a rad53-K227A kinase-dead protein (rad53-KD) (8) , but would nevertheless be hypomorphic. Analysis of autophosphorylation-site mutants would thus allow us to parse the functional significance of autophosphorylation from the initial Mec1/Tel1 (PIKK)-dependent transphosphorylation. We further hypothesized that phenotypic and molecular analyses of rad53 autophosphorylation-site mutants might lead to identification of mediators of Rad53 function involved in the signal amplification.
We mutated both T354 and T358 or T354 alone to alanines and examined the rad53-T354AT358A (rad53-TA) or rad53-T354A mutants to test the hypothesis. Although in vitro and in vivo assessments revealed that autophosphorylation mutants specify limited activity, the PIKK phosphorylation-induced protein interaction of rad53-TA and rad53-T354A with Rad9 and Dun1 were unaffected. rad53-TA and rad53-T354A exhibited sensitivity to hydroxyurea (HU) and methyl methanesulfonate (MMS), but were more proficient in checkpoint signaling than rad53-KD. We screened for high-copy suppressors that could compensate for impaired Rad53 autophosphorylation. We reasoned that two general categories of gene products would suppress the rad53-TA phenotype when present at elevated levels: Proteins that are regulated by Rad53 (i.e., Rad53 substrates) and, when overexpressed, would compensate for reduced Rad53 activity; second, proteins that interact with Rad53 and direct the active kinase to particular targets. When overexpressed, this class of proteins might potentiate the interaction of the partially active kinase with its targets. This category could include proteins that govern the transition to, and stabilize the active conformation of, the kinase. Alternatively, mediators that function downstream of Rad9, or proteins that enhance interaction with mediator proteins could also emerge from this screen.
We obtained 14-3-3 paralogs, BMH1 and BMH2, multiple times upon screening for resistance of rad53-TA and rad53-T354A to HU. The data obtained support a functional interaction of Bmh1/2 in the Rad53 checkpoint pathway and suggest that these proteins may be mediators of Rad53 activity.
Results
In Vitro Properties of rad53-TA and rad53-T354A. We established two rad53 alleles in which autophosphorylation sites in the activation loop were altered, rad53-T354A and the doubly mutant allele rad53-T354A T358A (rad53-TA). Previous analyses of the kinasedead rad53-K227A D339A gene product demonstrate that PIKKdependent protein interactions are unaffected by the lack of Rad53 autophosphorylation (19) . To examine whether these interactions were also unaffected in rad53-TA and rad53-T354A, a Flag epitope was targeted to the 3Ј end of rad53-TA and rad53-T354A loci. Immunoprecipitation (IP) from extracts of wild-type, rad53-KD-, rad53-TA-, and rad53-T354A-expressing cells was carried out. rad53-TA, rad53-T354A, and rad53-KD were coprecipitated with Rad9 after MMS treatment in a manner indistinguishable from wild type (Fig. 1A) . These data suggest that the alterations in Rad53 do not affect Mec1/Tel1 phosphorylation of Rad9.
DNA damage also induces the interaction of Rad53 with its substrate, Dun1 (18, 19) . Dun1-Myc and Flag-Rad53, -rad53-KD, -rad53-TA or -rad53-T354A-expressing cells were tested. Myc IPs from their extracts showed that rad53-TA and rad53-T354A as well as rad53-KD and wild type coprecipitated with Dun1 following treatment with MMS (Fig. 1B) . This interaction takes place through the Dun1 FHA domain, which preferentially binds phosphorylated residues (3, 18, 19) , supporting the view that rad53-TA and rad53-T354A are phosphorylated by Mec1/Tel1.
The residual activity of the rad53 autophosphorylation mutants was assessed in vitro. Rad53 (Flag) IP from extracts of MMS-treated cells were performed, and the ability of rad53 mutants to autophosphorylate was measured by using in vitro kinase assays. No autophosphorylation was detected in rad53-KD and rad53-TA, whereas rad53-T354A exhibited 12.0% of autophosphorylation seen in wild-type extracts of MMStreated cells (Fig. 1C) . The residual activity observed may reflect the contribution of additional autophosphorylation sites in Rad53 (12, 20) . Purified GST-dun1-KD proteins were also used as a substrate to assess the activity of rad53 mutant proteins (18) . No appreciable increase of Dun1 phosphorylation was seen in rad53-TA or rad53-KD IPs, whereas 4.7-fold and 2.1-fold increases were observed in the wild-type and rad53-T354A IPs, respectively (Fig. 1C) . When an artificial substrate, histone H1, was used, significant phosphorylation of histone H1 by wild type but not rad53-T354A was detected (data not shown).
Collectively, these data indicate that the rad53 autophosphorylation mutants behave essentially as wild type with regard to DNA damage-dependent protein interactions and that the in vitro activities of rad53-TA and, to a lesser degree, rad53-T354A are markedly reduced. These observations suggest that intracellular disposition of the rad53 mutants is largely normal and that the mutant proteins do not exhibit gross structural aberrations.
rad53-TA and rad53-T354A Exhibit Limited Activity in Vivo. To fully address the significance of Rad53 autophosphorylation in checkpoint signaling, we assessed the in vivo functionality of rad53-TA and rad53-T354A in response to HU-, MMS-, and cdc13-induced DNA damage. Response to each of these genotoxic stresses requires Rad53, but involves distinct sensors and mediators (1, 2) . We found that their in vivo functions were compromised, but to a significantly lesser degree than rad53-KD. To assess the response of Rad53 autophosphorylation mutants to DNA replication stress, rad53-TA, rad53-T354A, rad53-KD, and RAD53 were synchronized in G 1 with ␣-factor and released into media containing 200 mM HU. Viability was tested by colony formation on plates without HU after 0, 2 and 4 h of HU treatment. After 4 h treatment, viability of rad53-KD and rad53-TA was 1.0%, whereas rad53-T354A was 2.5% ( Fig. 2A) , consistent with rad53-T354A's higher level of activity in vitro (Fig. 1C) .
MMS sensitivity was also assessed. Asynchronous cultures of rad53-TA, rad53-T354A, rad53-KD, and RAD53 were treated for 20 min with varying concentrations of MMS and plated to assess viability by colony formation (Fig. 2B ). rad53-T354A was 5-fold more resistant, and rad53-TA was 3-fold more resistant than rad53-KD at 0.9% MMS, indicating that both mutants retain greater activity in vivo than rad53-KD.
rad53-TA and rad53-T354A were more proficient than rad53-KD in the activation of the S/M checkpoint, which inhibits mitosis when DNA replication is blocked. Tubulin was immunostained to monitor spindle morphology 3 h after release from G 1 arrest into HU-containing media. rad53-KD, rad53-TA, and rad53-T354A cells, 29.3%, 22.7%, and 15.0%, respectively, showed elongated spindle, indicative of mitosis, whereas 2.3% of wild-type cells did (Fig. 2C) . Thus, the S/M checkpoint defect in rad53 autophosphorylation mutants is less severe than rad53-KD.
The ability of rad53-TA and rad53-T354A to mount the G 2 /M DNA damage cell-cycle checkpoint response was tested in the cdc13-1 cdc15-2 (cdc13 cdc15) strain (Fig. 2D) . In checkpointproficient (i.e., RAD53) cdc13 cdc15 cells, cdc13 is inactivated at the restrictive temperature, causing telomere damage and cell cycle arrest at G 2 /M, whereas checkpoint mutants do not arrest at G 2 /M but divide nuclei and arrest at telophase because of the cdc15 (21, 22) . As expected, upon shift to the restrictive temperature after release from G 1 arrest, RAD53 cdc13 cdc15 cells arrested at G 2 /M over the course of the experiment. rad53-KD cells started dividing at least 1 h earlier than rad53-TA cells. At 6 h at the restrictive temperature, 50-60% of the rad53-KD and rad53-TA cells had undergone nuclear division, whereas only 20% of rad53-T354A had done so (Fig. 2D ). These data indicated that the autophosphorylation mutants retained in vivo function, with the checkpoint proficiency of rad53-T354A greater than rad53-TA or rad53-KD, whereas rad53-TA was more proficient that rad53-KD.
14-3-3 Palalogs BMH1 and BMH2 Are High-Copy Suppressors of rad53-TA. The data above demonstrate that rad53-TA and rad53-T354A retain residual activity, which we propose is conferred by Mec1/Tel1 phosphorylation. To identify proteins that functionally interact with basally active Rad53, we carried out a high-copy suppressor screen for genes that could alleviate the HU sensitivity of rad53-TA and rad53-T354A. The rad53-TA and rad53-T354A strains were transformed with a high-copy yeast genomic library, and transformants were tested for growth on 20 mM and 40 mM HU-containing plates, respectively (Table 1) . Among the suppressors obtained was the histone chaperone ASF1 (three independent clones), previously identified as a high-copy suppressor of rad53-21 HU sensitivity (23) , and the WD40-containing transcription modulator WTM2 (24) (one clone) ( Table 1) . WTM2 was recently identified as a high-copy suppressor of mec1⌬ HU sensitivity and implicated in ribonucleotide reductase (RNR) regulation (25) .
The most commonly obtained suppressors were S. cerevisiae 14-3-3 paralogs, BMH1 and BMH2 (four independent clones, two each), in the rad53-TA screen and in 10 independent clones (five each) in the rad53-T354A screen ( Table 1 ). The 14-3-3 proteins are highly conserved eukaryotic proteins that regulate diverse biological processes by governing the disposition of phosphorylated proteins (26, 27) . In S. cerevisiae, complete 14-3-3 deficiency is lethal, but single bmh⌬ mutants are unaffected (28) . The 14-3-3 proteins function in hetero-and homodimeric complexes and have been implicated in DNA damage-dependent cell cycle regulation in S. cerevisiae and S. pombe as well as in mammals (29) (30) (31) (32) (33) .
The possibility that suppression was attributable to bypass of Rad53 function was excluded by three lines of evidence. First, the effect is allele-specific. Whereas BMH1/2 overexpression increased viability of rad53-TA at 20 mM HU, it had no effect on the HU sensitivity of rad53-KD, rad53⌬, or rad53-21 ( Fig. 3 A  and B) . In contrast, rad53-21 HU sensitivity was suppressed by WTM2 and ASF1 overexpression (Fig. 3B) (23) .
Second, the strength of suppression was correlated with the level of residual Rad53 activity in rad53-TA and rad53-T354A. BMH2 could not suppress the lethality of rad53-TA in 40 mM HU, whereas it did increase resistance of the more active rad53-T354A allele (Fig. 3C) .
Finally, BMH1/2 suppression was not restricted to HU sensitivity. After 6-h incubation in 0.03% MMS, the viability of rad53-TA cells carrying a BMH2 high-copy plasmid (0.1%) was 5-fold higher than that of rad53-TA cells carrying a WTM2 high-copy or empty plasmid (SI Fig. 8 ). The toxicity of HU, but not MMS, arises from perturbation of nucleotide pools; it is therefore unlikely that BMH2 overexpression mitigates rad53-TA indirectly through an effect on nucleotide levels. Consistently, sml1⌬ did not suppress rad53-TA (data not shown, Fig. 4 A and  B) . These data indicate that the mechanism of BMH1 and BMH2 suppression is direct and appears to be distinct from that of WTM2 and ASF1.
Genetic Requirements of BMH2 Suppression. The specificity of BMH1/2 suppression supports the hypothesis that 14-3-3 proteins influence Rad53 functions in the normal physiological context and predicts that the genetic requirements of suppression should mirror those of Rad53 function itself. Activation of Rad53 depends on its phosphorylation by Mec1 and Tel1, an event that requires the mediator proteins, Mrc1 and Rad9 in response to DNA replication stress and DNA damage, respectively (5-7). After 6-h treatment with 20 mM HU in liquid culture, BMH2 overexpression increased viability of rad53-TA, mrc1⌬ rad53-TA, Screening size Ϸ7,000 Ϸ7,000
The numbers in parentheses represent the numbers of independent clones obtained from the screenings. and rad9⌬ rad53-TA up to 8-, 9-, and 20-fold (Fig. 4A) ; however, BMH2 suppression was blocked in mrc1⌬ rad9⌬ rad53-TA cells (Fig. 4B) , a context in which Rad53 phosphorylation by Mec1/ Tel1 is abrogated (7) . These data suggest that Bmh2's functional interaction with Rad53 requires phosphorylation of Rad53 by Mec1/Tel1.
Whereas suppression was unaffected by Chk1 deficiency (data not shown), BMH2 overexpression failed to suppress HU sensitivity in Dun1-deficient rad53-TA and rad53-T354A strains ( Fig. 4C and SI Fig. 9 ). Suppression appeared to require physical interaction between Rad53 and Dun1. The HU sensitivity of dun1-S74A H77A (dun1-fha) rad53-TA cells, in which Rad53-Dun1 interaction is abolished (18) , was unaffected by BMH2 overexpression (Fig. 4C) . These data indicate that BMH2 suppression requires DNA damage-induced formation of the Rad53-Dun1 complex.
The effect of BMH1/2 on clastogen sensitivity was correlated with the mitigation of rad53-TA checkpoint defects. rad53-TA cdc13 cdc15 cells were transformed with RAD53, BMH2, and empty plasmids (Fig. 4D) . As expected, upon shift to the restrictive temperature, RAD53-transformed rad53-TA cells arrested at G 2 /M over the course of the experiment, whereas nuclear division was observed in 60% of control rad53-TA transformants. In contrast, nuclear division was substantially reduced in BMH2-overexpression rad53-TA. This suppression of the G 2 /M checkpoint defect was lost in the dun1⌬ rad53-TA mutant (Fig. 4D) . These data suggest that Bmh2 modulates the functional interaction of Rad53 and Dun1 required for the G 2 /M DNA-damage cell-cycle checkpoint.
Physical Interaction of Bmh1/2 with Rad53. 14-3-3 proteins preferentially bind phosphopeptide (34) (35) (36) . The apparent requirement for Mec1/Tel1 phosphorylation of Rad53 in BMH2 suppression raised the possibility that Bmh2 interacted with Rad53 in response to DNA damage. To test this possibility, Bmh2 IPs were carried out from extracts of MMS-treated Flag-Rad53-, -rad53-TA-, -rad53-KD-expressing cells. All three forms of Rad53 were present in Bmh1/2 immunoprecipitates from extracts of MMS-treated cells but not asynchronously growing untreated cells (Fig. 5A) , indicating that Bmh1/2 interacts with Rad53 in response to DNA damage. The data also suggest that the Bmh1/2-Rad53 interaction is not dependent on Rad53 autophosphorylation.
The lack of suppression in mrc1⌬ rad9⌬ rad53-TA suggested that the Bmh1/2-Rad53 interaction was influenced by Mec1/ Tel1-dependent phosphorylation. The interaction was therefore examined in mec1 tel1⌬ strains. Coprecipitated Rad53 was slightly reduced in Bmh2 immunoprecipitates from MMStreated mec1 cell extracts, but was substantially reduced in mec1 tel1⌬ cell extracts (Fig. 5B) . Phosphatase treatment of Bmh2 IPs liberated Rad53 from immunoprecipitate, confirming that the interaction depends on phosphorylation (SI Fig. 10 ). Collectively, these data favor the interpretation that Bmh2 engages basally activated (i.e., Mec1/Tel1-phosphorylated, nonautophosphorylated) Rad53 in response to DNA damage and replication stress.
Phosphopeptide-Binding Site bmh2 Mutants. A second prediction of the hypothesis that Bmh1/2 mediate Rad53 functions under physiological conditions is that bmh2 mutants impaired for Rad53 interaction would phenocopy Rad53 hypomorphism. These mutants should also fail to suppress rad53-TA when overexpressed. We examined random amino acid substitutions at the two phosphopeptide-binding sites of Bmh2, K51 and E185. K51 is critical for formation of the phosphopeptide-binding pocket, and E185 determines the binding specificity of phosphopeptides to 14-3-3 (35, 36) . We identified five bmh2K51x mutants (x ϭ F, G, L, P, R) and a bmh2-E185D mutant that exhibited reduced suppression of HU sensitivity relative to BMH2 upon overexpression in bmh1⌬ bmh2⌬ rad53-TA cells. An additional binding-site mutant, bmh2-L225Q, was constructed based on the bmh1-170 allele (L225Q E244V E262X) which exhibited HU sensitivity and genomic instability (32) . Mutations that abolished dimerization (37) were neither able to suppress rad53-TA nor to support viability of bmh1⌬ (data not shown) and were not analyzed further. Conversely, the phosphopeptidebinding site bmh2 mutants retained sufficient functionality to support the viability of a bmh1⌬ mutant but exhibited HU and MMS sensitivity when expressed from the BMH2 genomic locus, (Fig. 6B and data not shown) . All bmh2-K51x and bmh2-E185D mutants suppressed rad53-TA Ϸ10-fold less than BMH2 at 10 mM HU but failed to suppress at 20 mM HU, whereas bmh2-L225Q did not suppress at all (Fig. 6A) . These data suggest that phosphopeptide binding is required for the suppression, consistent with the observation that Rad53-Bmh2 interaction depends on Rad53 phosphorylation.
Because Rad53 and Dun1 govern the G 2 /M DNA damagecheckpoint defect (18, 38) , we tested the prediction that the nonbinding mutants would phenocopy Rad53 hypomorphism in that function. At 6 h, at the restrictive temperature after G 1 arrest release, 25% of the bmh2-K51L and bmh2-K51R cells underwent nuclear division in bmh1⌬ cdc13 cdc15 (Fig. 6C) , approximately 3-fold more than wild-type cells.
Consistent with the phosphopeptide-binding functions of K51 and E185, the G 2 /M checkpoint defects observed were correlated with reduced Rad53 interaction. Bmh2 IPs were performed in the genomic phosphopeptide-binding site bmh2 mutants in the bmh1⌬ background. Rad53 was significantly reduced in IPs from MMStreated bmh2-K51L, K51R, L225Q, and E185D cells compared with wild-type cells (Fig. 6D) . These data strongly support the interpretation that Bmh2-Rad53 interaction is important for Rad53-dependent checkpoint functions and suggest that Bmh1/2 function as mediators of Rad53 and Dun1 activity in vivo.
Discussion
In this study, we examined the functional outcomes of Rad53 autophosphorylation and Rad53 phosphorylation by Mec1/Tel1. rad53 mutations that impair autophosphorylation markedly reduce in vitro activity; however they retain a significantly greater degree of checkpoint function in vivo than rad53-KD mutants. These observations support the view that Mec1/Tel1-phosphorylation of Rad53 may basally activate the kinase. We also observed that DNA damage-induced interactions of rad53-KD, rad53-TA, and rad53-T354A with mediator proteins and the Rad53 substrate Dun1 were unaffected. The experiments performed here do no exclude the possibility that Rad53 may have inherent basal activity in vivo and that the primary function of PIKK-mediated phosphorylation is to promote physical interaction of the basally active kinase with other effectors and mediators of the DNA damage response. In either case, these associations culminate in Rad53 autophosphorylation and its full activation.
The suppression of rad53-TA and rad53-T354A HU sensitivity by BMH1/2 overexpression revealed a previously unrecognized aspect of Rad53 regulation. Several lines of evidence support the interpretation that Bmh1/2 facilitate Rad53 functions in vivo. Bmh1/2 physically interact with Rad53 in a DNA damagedependent manner; accordingly, this interaction is promoted by Mec1/Tel1 phosphorylation of Rad53. bmh2 mutants in which physical interaction with Rad53 is lost fail to suppress rad53-TA when overexpressed and phenocopy rad53 hypomorphism when expressed normally in a RAD53 wild-type strain. Finally, the genetic requirements for BMH1/2 suppression mirror those of Rad53 activity itself.
The functional interaction of Rad53 and Bmh1/2 in S. cerevisiae demonstrates that 14-3-3 proteins can directly influence checkpoint signaling. This finding contrasts with the mechanism of 14-3-3 protein checkpoint functions in S. pombe and human cells. In those settings, 14-3-3 proteins indirectly regulate Cdk1 in response to DNA damage by targeting the Cdc25 phosphatase, which removes inhibitory phosphorylation of Y15 (33, (39) (40) (41) (42) (43) , although the different mode of 14-3-3 functions on Cdk1 regulation has not been excluded (44) . This event is initiated when DNA damage induces Chk1-and Cds1-dependent phosphorylation of Cdc25, which creates a 14-3-3-binding site. The 14-3-3 then associates with Cdc25, leading to its sequestration in the cytoplasm, effectively blocking its ability to activate Cdk1. In S. cerevisiae checkpoint signaling, the Y19 in Cdc28 kinase (equivalent to Y15 of Cdc2), does not appear to be the nexus of DNA damage-dependent Cdk regulation (45, 46) . Consistent with this fact, we found that Mih1, the S. cerevisiae Cdc25 ortholog, is not required for BMH2 suppression of rad53-TA (data not shown).
The intracellular localization of Chk1 is also modulated by 14-3-3 proteins in S. pombe and mammals during the response to DNA damage (47) (48) (49) . Given that DNA damage-induced protein interactions of Rad53 autophosphorylation mutants are indistinguishable from wild-type Rad53, it is unlikely that Bmh1/2's effect is attributable to regulation of Rad53 localization. Chk1 deficiency does not exacerbate the HU sensitivity of rad53-TA, nor does it impair BMH2 suppression (data not shown), further supporting the view that the mechanisms of 14-3-3 interaction with Rad53 are distinct from those operative with Chk1.
The data presented here demonstrate that Bmh1/2 mediate Rad53 kinase activity in a direct manner, and suggest an analogy to the role of 14-3-3 proteins in the regulation of Raf-1 kinase (37) (reviewed in refs. 27 and 50). Like Rad53, the activity of Raf-1 kinase critically depends on phosphorylation in the activation loop (51) . Available evidence suggests that 14-3-3 interacts with Raf1 at four distinct phosphorylated residues. As some of the interactions enhance and others inhibit its activity, the 14-3-3 engagement of Raf1 appears to stabilize either inactive or active conformers of the kinase (50) . We propose that the binding of Bmh1/2 to Rad53 may similarly stabilize an active form of Rad53. Implicitly, this hypothesis predicts that BMH2 overexpression may stabilize an active conformation in rad53-TA and rad53-T354A, allowing access of Rad53 substrates (e.g., Dun1) to the catalytic site. Because BMH2 overexpression does not suppress rad53-21, this E365K mutation (52) may preclude the required conformational changes.
A small fraction of Rad53 DNA damage-induced interaction with Bmh1/2 was Mec1/Tel1-independent, raising the possibility that Rad53 may have two Bmh1/2-binding sites; one is the Mec1/ Tel1 phosphorylation site, and another is the Mec1/Tel1-independent interaction site. The putative second site may depend on a different kinase, but it is noteworthy that 14-3-3 protein binding to nonphosphorylated peptides has been observed (e.g., refs. 53 and 54). Because BMH2 suppression of rad53-TA was lost in dun1-fha, the functional interaction of Bmh1/2 with Rad53 appears to require formation of the Rad53/Dun1 complex. Based on the ability of 14-3-3 to act as phosphorylation-dependent molecular scaffolds, Rad53-bound Bmh1/2 could provide a structure that influences the FHA-mediated interaction of Dun1 with Rad53. We therefore hypothesize that Bmh1/2 act in a manner that is analogous to a mediator protein such as Rad9 to facilitate the activity of Rad53. In this conception, the 14-3-3 is envisaged to stabilize the active form of the kinase and thereby its interaction with substrates such as Dun1. Consistent with this model, dun1⌬ did not diminish the Bmh1/2-Rad53 interaction (data not shown).
Finally, Bmh1/2 binding to Rad53 may antagonize PP2C, the phosphatase that attenuates Rad53 phosphorylation during adaptation and recovery from checkpoint (55) . The phosphorylation of Rad53 induced by UV irradiation appears to be less stable in bmh1 alleles associated with G 1 /S and G 2 /M checkpoint defects (32) , and there is precedent for 14-3-3 proteins regulating the access of regulatory phosphatases. For example, 14-3-3 binding to Ser-621 of Raf1 prolongs the phosphorylation at this site and thus preserves the active state of the kinase (56) . In this context, Bmh1/2 may protect the Mec1/Tel1-phosphorylated sites of Rad53 responsible for the Dun1 FHA binding, which could account for the BMH2 suppression in rad53-TA and rad53-T354A.
Collectively, these data offer insight regarding the mechanism by which 14-3-3 proteins regulate the cellular DNA damage response. Given the strong conservation of both Rad53 and 14-3-3, it is likely that similar mechanisms are operative in mammalian cells. The clearly established role for Chk2, the mammalian Rad53 ortholog in tumor suppression and apoptotic regulation, suggest that interdiction of 14-3-3 functions may provide a useful therapeutic strategy.
Materials and Methods
The information of yeast strains, plasmids, and their construction and the detailed methods are published as SI Methods.
IP and in Vitro Kinase Assay. IP and in vitro kinase assay were performed essentially as described (57) .
Genetic Analyses. Acute HU/MMS sensitivity and S/M checkpoint were examined essentially as described (57) . cdc13 cdc15 assay was performed as in ref. 22 .
High-Copy Suppressor Screening. JPY1300 (rad53-TA) and JPY2154 (rad53-T354A) were transformed with a yeast genomic high-copy library. rad53-TA and rad53-T354A transformants were screened on 20 mM HU and 40 mM HU plates, respectively.
Phosphopeptide-Binding Site bmh2 Mutants. bmh2K51x and E185x mutant libraries were obtained by the QuikChange PCR method using random-synthesized primers. bmh2-L225Q was generated by the QuikChange PCR. The bmh2 genomic mutants were made as mentioned (32) .
We thank Wolf Heyer (University of California, Davis, CA) for GSTdun1-KD protein and dun1 mutant yeast strains; Sandra Lemmon (University of Miami, Miami, FL) for Bmh2 antisera; Steve Elledge, Chris Lima, Rodney Rothstein, and Ted Weinert for materials; Annalee Baker and Eshtel Beauge for superb technical assistance; members of their laboratories for insights; and Andy Koff and Rob Fisher for critical reading of the manuscript. This work was supported by National Institutes of Health Grants GM56888 and GM59413 and the Joel and Joan Smilow Initiative (J.H.J.P.). T.U. is a Special Fellow of the Leukemia and Lymphoma Society.
